Multicenter Experience of Nonpegylated Liposomal Doxorubicin Use in the Management of Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Multicenter Experience of Nonpegylated Liposomal Doxorubicin Use in the Management of Metastatic Breast Cancer

Published:2014-04 Issue:2 Volume:14 Page:85-93
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Palmieri Carlo,Misra Vivek,Januszewski Adam,Yosef Hosney,Ashford Richard,Keary Ian,Davidson Neville

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference18 articles.

1. Treatment for anthracycline-pretreated metastatic breast cancer;O'Shaughnessy;Oncologist,2002

2. National Institute for Health and Care Excellence. CG81: Advanced Breast Cancer: Diagnosis and Treatment. 2009. Available at: http://publications.nice.org.uk/advanced-breast-cancer-cg81. Accessed: November 2012.

3. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

4. Cytotoxic and hormonal treatment for metastatic breast cancer: a systemic review of published randomised trials involving 31,510 women;Fossati;J Clin Oncol,1998

5. Chemotherapy with and without anthracycline (in reply);Fossati;J Clin Oncol,2000

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anthracycline-induced cardiotoxicity — are we about to clear this hurdle?;European Journal of Cancer;2023-05

2. Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer;Journal of Ovarian Research;2022-08-16

3. The Synthesis of Nano-Doxorubicin and its Anticancer Effect;Anti-Cancer Agents in Medicinal Chemistry;2021-12-23

4. Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin;Scientific Reports;2020-10-28

5. Cardiotoxicity of Cancer Therapies;Cardiology in Review;2019-09